Genome Engineering of Pichia pastoris

1. Strain Characteristics and Biological Background

Pichia pastoris (now classified as Komagataella phaffii) is an important methylotrophic yeast widely used in biotechnology. It is one of the most commonly used eukaryotic expression hosts, even surpassing Saccharomyces cerevisiae, and is extensively applied for protein production in both basic and applied research.

1.1 Pichia pastoris offers the following significant advantages:

(1) High protein expression capability: Capable of efficiently expressing various heterologous proteins, including complex eukaryotic proteins, with certain post-translational modification capabilities such as glycosylation, making the expressed proteins closer to their native state.

(2) Excellent growth characteristics: Can grow rapidly in simple culture media with low cultivation costs, suitable for large-scale fermentation production.

(3) Relatively straightforward genetic manipulation: Although its homologous recombination efficiency is lower than that of S. cerevisiae, efficient gene editing can be achieved by optimizing technical means, such as the CRISPR/Cas9 system introduced in this document.

1.2 In terms of applications, Pichia pastoris is primarily used for:

(1) Recombinant protein production: e.g., production of therapeutic proteins, enzymes, antibodies, etc.

(2) Metabolic engineering: Used to engineer metabolic pathways for the production of biofuels, chemicals, etc.

(3) Synthetic biology research: Serves as a model organism for constructing artificial biological systems and studying gene function.

2. Pichia pastoris Gene Editing Workflow

2.1 Vector Construction

(1) Cas9 Expression Vector Construction: Select an appropriate Cas9 sequence, place it under the control of a strong constitutive promoter, and fuse it with a nuclear localization sequence to ensure Cas9 enters the nucleus.

(2) gRNA Expression Vector Construction: Design gRNA sequences targeting the gene of interest, typically selecting multiple gRNAs to improve editing efficiency.

2.2 Transformation and Screening

(1) Cell Transformation: Introduce the constructed CRISPR/Cas9 plasmids into competent P. pastoris cells using electroporation.

(2) Screening Positive Clones: Culture transformants on antibiotic-containing media to screen for clones successfully incorporating the plasmid.

2.3 Gene Editing and Verification

(1) Gene Editing Occurrence: The Cas9-gRNA complex recognizes the target gene sequence within the nucleus and cleaves the DNA. The cell repairs the break via Non-Homologous End Joining (NHEJ) or Homologous Recombination (HR), achieving gene knockout, knock-in, or replacement.

(2) Genotype Verification: Extract genomic DNA from transformants, amplify the target region by PCR and sequence it to verify the gene editing outcome, such as the presence of insertions, deletions, or substitution mutations.

(3) Phenotype Analysis: Perform corresponding phenotypic assays based on the target gene's function. For example, knocking out the GUT1 gene leads to growth defects on media with glycerol as the carbon source; mutant strains can be screened based on growth on glycerol plates.

Genome Engineering Strategies for Pichia pastoris

3. Pichia pastoris Gene Editing Service Types

3.1 Gene Knockout Services

(1) Single Gene Knockout: Design gRNAs targeting a single gene, utilizing the CRISPR/Cas9 system for efficient gene knockout. Suitable for studying gene function, constructing gene deletion strains, etc.

(2) Multiplex Gene Knockout: Simultaneously express multiple gRNAs to achieve knockout of multiple genes concurrently. Useful for studying gene-gene interactions, metabolic pathway reconstruction, etc.

3.2 Gene Knock-in and Replacement Services

(1) Marker Gene Insertion: Insert a marker gene (e.g., Zeocin resistance gene) at the target locus for screening and tracking edited cells.

(2) Homologous Recombination-Mediated Gene Replacement: Provide a homologous donor DNA cassette, co-transformed with the CRISPR/Cas9 system, to achieve targeted gene replacement or specific sequence insertion via homologous recombination. Applicable for gene complementation studies, protein tag addition, etc.

3.3 Customized Gene Editing Services

Design specific gene editing solutions based on client requirements: including promoter engineering, metabolic pathway optimization, protein expression optimization, etc., to meet specific needs in basic research or industrial production.

4. Pichia pastoris Gene Editing Technical Advantages

4.1 High Efficiency

By optimizing the Cas9 and gRNA expression systems, gene editing efficiency can approach 100%. For genes difficult to edit by traditional methods (e.g., OCH1), the CRISPR/Cas9 system offers approximately 50 times higher editing efficiency compared to traditional knockout cassette methods.

4.2 Precision

The CRISPR/Cas9 system uses gRNA to precisely guide Cas9 to the target site, enabling precise editing. By designing different gRNAs and donor DNA, various precise genetic operations can be achieved, such as single base pair mutations, fragment insertions, or deletions.

4.3 Flexibility

Simply changing the 20 bp sequence of the gRNA allows retargeting to different genetic loci. Compared to other gene editing technologies like TALENs, operation is simpler and more flexible. Supports multiplex editing, enabling simultaneous modification of multiple genes within the same strain, accelerating metabolic pathway engineering and strain optimization.

4.4 Marker-Free Editing

Utilizing plasmids constructed with autonomous replication sequences allows for plasmid curing via non-selective culture, thereby obtaining genetically edited strains without selectable markers, avoiding potential impacts of marker genes on subsequent research or production.

4.5 Broad Applicability

Can be used to edit various genes in Pichia pastoris, including key genes involved in methanol metabolism (e.g., AOX1, MXR1, TRM1, MPP1) and genes affecting protein glycosylation (e.g., OCH1).

5. Project Timeline

(1) Standard Pichia pastoris Strains: 2-3 months

(2) Wild Pichia pastoris Strains: Customized projects requiring specific evaluation.

6. Delivery Standards

(1) Target site PCR and DNA sequencing verification data.

(2) Two glycerol stocks of the engineered strain.

(3) mRNA transcription level data (for overexpression projects).

(4) Project final report.